Logo image of NXI.PA

NEXITY (NXI.PA) Stock Fundamental Analysis

EPA:NXI - Euronext Paris - Matif - FR0010112524 - Common Stock - Currency: EUR

9.29  -0.2 (-2.11%)

Fundamental Rating

3

Overall NXI gets a fundamental rating of 3 out of 10. We evaluated NXI against 69 industry peers in the Real Estate Management & Development industry. NXI may be in some trouble as it scores bad on both profitability and health. NXI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NXI had negative earnings in the past year.
NXI had a positive operating cash flow in the past year.
Of the past 5 years NXI 4 years were profitable.
Each year in the past 5 years NXI had a positive operating cash flow.
NXI.PA Yearly Net Income VS EBIT VS OCF VS FCFNXI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

NXI's Return On Assets of -0.96% is in line compared to the rest of the industry. NXI outperforms 50.72% of its industry peers.
The Return On Equity of NXI (-3.44%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.96%
ROE -3.44%
ROIC N/A
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
NXI.PA Yearly ROA, ROE, ROICNXI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Gross Margin value of 23.27%, NXI perfoms like the industry average, outperforming 44.93% of the companies in the same industry.
NXI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
NXI.PA Yearly Profit, Operating, Gross MarginsNXI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

NXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
NXI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXI has more shares outstanding
NXI has a worse debt/assets ratio than last year.
NXI.PA Yearly Shares OutstandingNXI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NXI.PA Yearly Total Debt VS Total AssetsNXI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NXI has an Altman-Z score of 0.95. This is a bad value and indicates that NXI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.95, NXI is in line with its industry, outperforming 56.52% of the companies in the same industry.
The Debt to FCF ratio of NXI is 12.06, which is on the high side as it means it would take NXI, 12.06 years of fcf income to pay off all of its debts.
NXI has a Debt to FCF ratio of 12.06. This is in the better half of the industry: NXI outperforms 75.36% of its industry peers.
NXI has a Debt/Equity ratio of 0.86. This is a neutral value indicating NXI is somewhat dependend on debt financing.
NXI has a Debt to Equity ratio of 0.86. This is comparable to the rest of the industry: NXI outperforms 52.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 12.06
Altman-Z 0.95
ROIC/WACCN/A
WACC2.77%
NXI.PA Yearly LT Debt VS Equity VS FCFNXI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

NXI has a Current Ratio of 1.26. This is a normal value and indicates that NXI is financially healthy and should not expect problems in meeting its short term obligations.
NXI has a Current ratio (1.26) which is comparable to the rest of the industry.
NXI has a Quick Ratio of 1.26. This is a bad value and indicates that NXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NXI (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.75
NXI.PA Yearly Current Assets VS Current LiabilitesNXI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

NXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -525.59%.
NXI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.93%.
NXI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.52% yearly.
EPS 1Y (TTM)-525.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1303.87%
Revenue 1Y (TTM)-15.93%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-15.47%

3.2 Future

The Earnings Per Share is expected to grow by 30.16% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -4.00% on average over the next years.
EPS Next Y16.57%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
EPS Next 5YN/A
Revenue Next Year-19.95%
Revenue Next 2Y-8.31%
Revenue Next 3Y-4%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NXI.PA Yearly Revenue VS EstimatesNXI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
NXI.PA Yearly EPS VS EstimatesNXI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXI. In the last year negative earnings were reported.
Also next year NXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXI.PA Price Earnings VS Forward Price EarningsNXI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NXI indicates a rather cheap valuation: NXI is cheaper than 92.75% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NXI indicates a rather cheap valuation: NXI is cheaper than 94.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.83
EV/EBITDA 9.68
NXI.PA Per share dataNXI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

A more expensive valuation may be justified as NXI's earnings are expected to grow with 30.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.57%
EPS Next 3Y30.16%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 17.45%, NXI is a good candidate for dividend investing.
In the last 3 months the price of NXI has falen by -26.33%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 7.55, NXI pays a better dividend. On top of this NXI pays more dividend than 94.20% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, NXI pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.45%

5.2 History

The dividend of NXI decreases each year by -0.01%.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years2
NXI.PA Yearly Dividends per shareNXI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
NXI.PA Yearly Income VS Free CF VS DividendNXI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

NEXITY

EPA:NXI (5/21/2025, 7:00:00 PM)

9.29

-0.2 (-2.11%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-24 2025-07-24
Inst Owners35.85%
Inst Owner ChangeN/A
Ins Owners2.77%
Ins Owner ChangeN/A
Market Cap521.45M
Analysts78
Price Target11.65 (25.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 17.45%
Yearly Dividend2.51
Dividend Growth(5Y)-0.01%
DP0%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.16%
PT rev (3m)-20.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-806.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.36%
Revenue NY rev (3m)-13.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 2.83
P/OCF 2.25
P/B 0.29
P/tB 0.93
EV/EBITDA 9.68
EPS(TTM)-1.23
EYN/A
EPS(NY)-1.08
Fwd EYN/A
FCF(TTM)3.28
FCFY35.34%
OCF(TTM)4.12
OCFY44.39%
SpS59.38
BVpS32.27
TBVpS9.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -3.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.27%
FCFM 5.53%
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 12.06
Debt/EBITDA 8.13
Cap/Depr 23.15%
Cap/Sales 1.41%
Interest Coverage N/A
Cash Conversion 121.39%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.75
Altman-Z 0.95
F-Score4
WACC2.77%
ROIC/WACCN/A
Cap/Depr(3y)30.71%
Cap/Depr(5y)31.16%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-525.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1303.87%
EPS Next Y16.57%
EPS Next 2Y42.57%
EPS Next 3Y30.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.93%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-15.47%
Revenue Next Year-19.95%
Revenue Next 2Y-8.31%
Revenue Next 3Y-4%
Revenue Next 5YN/A
EBIT growth 1Y-106.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.95%
EBIT Next 3Y53.02%
EBIT Next 5YN/A
FCF growth 1Y2.9%
FCF growth 3Y62.63%
FCF growth 5Y-7.99%
OCF growth 1Y-3.1%
OCF growth 3Y33.4%
OCF growth 5Y-7.85%